Journey Advisory Group’s Stryker SYK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.45M Buy
4,424
+541
+14% +$194K 0.12% 122
2025
Q4
$1.36M Sell
3,883
-664
-15% -$242K 0.11% 135
2025
Q3
$1.68M Buy
4,547
+48
+1% +$18.5K 0.12% 128
2025
Q2
$1.78M Buy
4,499
+143
+3% +$53.5K 0.14% 130
2025
Q1
$1.62M Buy
4,356
+1,121
+35% +$427K 0.13% 118
2024
Q4
$1.1M Hold
3,235
0.13% 109
2024
Q3
$1.1M Hold
3,235
0.13% 109
2024
Q2
$1.1M Buy
3,235
+122
+4% +$41.3K 0.13% 109
2024
Q1
$1.11M Buy
3,113
+78
+3% +$26.2K 0.14% 108
2023
Q4
$909K Buy
3,035
+17
+0.6% +$4.77K 0.12% 115
2023
Q3
$825K Buy
3,018
+20
+0.7% +$5.74K 0.12% 118
2023
Q2
$915K Buy
2,998
+117
+4% +$33.8K 0.14% 117
2023
Q1
$822K Buy
2,881
+9
+0.3% +$2.39K 0.13% 124
2022
Q4
$702K Buy
2,872
+375
+15% +$85.1K 0.17% 111
2022
Q3
$506K Hold
2,497
0.13% 139
2022
Q2
$533K Buy
2,497
+15
+0.6% +$3.52K 0.12% 143
2022
Q1
$664K Buy
2,482
+438
+21% +$113K 0.17% 117
2021
Q4
$547K Buy
+2,044
New +$536K 0.15% 124

Other funds holding SYK

Journey Advisory Group's SYK Position: Q1 2026 in Review

Journey Advisory Group increased its Stryker (SYK) stake by 14% in Q1 2026, buying an estimated $194K and bringing the position to 4,424 shares worth $1.45M. The position accounts for 0.12% of the portfolio, ranked #122.

Journey Advisory Group first reported a position in SYK in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.78M in Q2 2025. 2,295 funds tracked by Wall St. Rank hold SYK as of Q1 2026.

  • Journey Advisory Group held 4,424 shares of Stryker worth $1.45M as of Q1 2026.
  • Journey Advisory Group bought 541 Stryker shares in Q1 2026, an estimated $194K.
  • Stryker made up 0.12% of Journey Advisory Group's portfolio in Q1 2026, its #122 holding.
  • Journey Advisory Group first reported a position in Stryker in Q4 2021 and has held it in 18 quarters since.
  • Journey Advisory Group's Stryker position peaked at $1.78M in Q2 2025.
  • 2,295 funds tracked by Wall St. Rank held Stryker as of Q1 2026.

Based on Journey Advisory Group's 13F filing for Q1 2026, filed 5 May 2026.